Table 5.
1st visit | 2nd visit | |
DAS-28 | 3.66 (0.63–6.72) | 3.22 (1.18–5.24) |
CRP, mg/dL | 0.54 (0.12–3.86) | 0.45 (0.15–3.04) |
CRVE, µm | 217.9 (160.81–247.2) | 215.5 (160.2–247.8) |
CRAE, µm | 147.1 (128.7–169.1) | 145.7 (120–165.5) |
HAQ-DI* | 0.2 (0–1.05) | 0.05 (0–0.95) |
Data are presented as median (min–max). Twenty-four (51%) of the 47 RA patients attended second visits. CRP: C-reactive protein; CRAE: central retinal arteriolar equivalent; CRVE: central retinal venular equivalent; DAS-28: Disease Activity Score-28; HAQ-DI: Health Assessment Questionnaire-Disability Index. *: HAQ-DI score was available for 13 patients.